Corrigendum to “Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia”
Saved in:
| Main Authors: | Suneeta James, Chaya Kapugama, Mohammed Al-Uzri |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Case Reports in Psychiatry |
| Online Access: | http://dx.doi.org/10.1155/2019/9595638 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Using Extended-Release Injectable Aripiprazole for the Successful Treatment of Depressive Symptoms in Bipolar I Disorder
by: Joseph Kuo, et al.
Published: (2020-01-01) -
A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia
by: Lakshmi Priya, et al.
Published: (2021-01-01) -
Dynamics of mental state and prolactin levels in patients with chronic schizophrenia during aripiprazole therapy
by: L. N. Gorobets, et al.
Published: (2023-10-01) -
Subjective well-being in early-phase schizophrenia patients using long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST)
by: Anna-Theresa Schulze, et al. -
Do Long-Acting Injectable Antipsychotics Influence Serum Levels of Brain-Derived Neurotrophic Factor in People With Schizophrenia and Schizoaffective Disorder?
by: Mirko Manchia, et al.
Published: (2024-01-01)